| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Product revenue | ||||||
- | - | - | - | - | 0 | - |
Total revenue | ||||||
- | - | - | - | - | - | 3,000 |
Product revenue | ||||||
- | - | - | - | - | 0 | - |
Cost of product revenue | ||||||
- | - | - | - | - | 0 | - |
Gross loss | ||||||
- | - | - | - | - | 0 | - |
Operating expenses | ||||||
Research and development | ||||||
16,267 | 7,178 | 3,069 | 2,247 | 0 | 2,242 | 2,379 |
Sales and marketing | ||||||
- | - | 26 | 0 | - | 252 | - |
General and administrative | ||||||
6,930 | 6,556 | 6,584 | 6,076 | 5,991 | 2,665 | 1,466 |
Change in fair value of contingent consideration | ||||||
289 | 567 | 2,492 | - | - | - | - |
Change in fair value of contingent consideration | ||||||
- | - | - | 0 | - | - | - |
Total operating expenses | ||||||
23,486 | 14,301 | 12,171 | 8,324 | 5,991 | 5,159 | 3,846 |
Operating loss | ||||||
-23,486 | -14,301 | -12,171 | -8,324 | -5,991 | -5,159 | -846 |
Other income (expense) | ||||||
Cease-use income | ||||||
- | - | 4 | -93 | 0 | - | - |
Interest expense, net | ||||||
- | - | - | - | - | 4,130 | 2,860 |
Interest income | ||||||
- | - | - | - | - | 1 | 1 |
Change in fair value of warrants liabilities | ||||||
6,964 | -522 | 685 | -1,667 | 515 | 3,941 | - |
Gain on deconsolidation of former subsidiary | ||||||
- | 1,994 | - | - | - | - | - |
Loss from minority interest investment | ||||||
-478 | -160 | - | - | - | - | - |
Other expense | ||||||
- | - | - | -13 | 183 | 7 | - |
Inducement charge for Series C warrants | ||||||
- | - | - | - | 3,049 | 0 | - |
Interest income | ||||||
154 | 104 | -590 | 1,586 | -3,748 | - | -1 |
Total other income (expense) | ||||||
-7,288 | 2,460 | -1,271 | - | - | - | - |
Loss from continuing operations before provision for income tax benefit | ||||||
- | - | -13,442 | -6,737 | - | - | - |
Provision for income tax benefit from continuing operations | ||||||
- | - | -1,650 | 0 | - | - | - |
Loss from continuing operations | ||||||
-30,774 | -11,841 | -11,792 | -6,737 | -9,740 | - | - |
Operating loss | ||||||
- | - | -3,399 | -5,327 | - | - | - |
Other expense | ||||||
- | - | -194 | - | - | - | - |
Loss on sale of assets | ||||||
- | - | - | 0 | - | - | - |
Loss from discontinued operations | ||||||
- | -1,494 | -3,593 | -5,327 | -6,168 | - | - |
Net loss | ||||||
-30,774 | -13,335 | -15,385 | -12,065 | -15,908 | -13,237 | -3,707 |
Loss per common share from continuing operations, basic and diluted | ||||||
-0.90 | -0.56 | -1.31 | 0.00 | -5.17 | - | - |
Loss on extinguishment of convertible preferred stock | ||||||
- | - | - | 3,651 | 0 | - | - |
Net loss applicable to common stockholders | ||||||
- | - | - | -15,716 | -15,908 | - | - |
Loss per common share from discontinued operations, basic and diluted | ||||||
- | -0.07 | -0.40 | -1.72 | -3.27 | - | - |
Net loss per common share, basic and diluted | ||||||
-0.90 | -0.64 | -1.71 | -5.07 | -8.44 | -10.42 | -6.92 |
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share | ||||||
34,142 | 20,975 | 8,977 | 3,101 | 1,885 | 1,270 | 535 |